.jpg)
LITERATURE REFERENCES
Ketamine for Trauma PTSD
Albott CS et al. Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression. J Clin Psychiatry. 2018 May/Jun;79(3).
​
Feder A et al. Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder, A Randomized Clinical Trial. JAMA Psychiatry. 2014;71(6):681–688.
Selected References Off-Label Use of Ketamine for Depression
-
Matveychuk D, Thomas RK, Swainson J, Khullar A, MacKay MA, Baker GB, Dursun SM. Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers. Ther Adv Psychopharmacol. 2020 May 11;10:2045125320916657. doi: 10.1177/2045125320916657. PMID: 32440333; PMCID: PMC7225830.
​​​​​​​
-
Grady SE, Marsh TA, Tenhouse A, Klein K. Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature. Ment Health Clin. 2017 Jan;7(1) 16-23.
​
-
Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nat Rev Neurosci, 11(9), 642-651.
​
-
Serafini, G. et al. NMDA receptor antagonists for depression: Critical considerations. Ann Clin Psychiatry (2015), 27(3), 213-220.
​
-
Serafini G, Howland RH, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: a systematic review. Curr Neuropharmacol. 2014;12(5):444-61.
​
-
Murrough, J. et al. Ketamine for rapid reduction of suicidal ideation: A randomized controlled trial. Psychological Medicine (2015), 45(16), 3571-3580.
References PRP
1. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001;10:225-228. [PubMed] [Google Scholar]
​
2. Tayapongsak P, O’Brien DA, Monteiro CB, Arceo-Diaz LY. Autologous fibrin adhesive in mandibular reconstruction with particulate cancellous bone and marrow. J Oral Maxillofac Surg 1994;52:161-165; discussion 166. [PubMed] [Google Scholar]
​
3. Lee KS, Wilson JJ, Rabago DP, et al. Musculoskeletal applications of platelet-rich plasma: fad or future? AJR Am J Roentgenol 2011;196:628-636. [PubMed] [Google Scholar]
​
4. LaPrade CM, James EW, LaPrade RF, Engebretsen L. How should we evaluate outcomes for use of biologics in the knee? J Knee Surg 2015;28:35-44. [PubMed] [Google Scholar]
​
5. Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg 2009;17:602-608. [PubMed] [Google Scholar]
​
6. Hsu WK, Mishra A, Rodeo SR, et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg 2013;21:739-748. [PubMed] [Google Scholar]
​
7. Mazzocca AD, McCarthy MB, Chowaniec DM, et al. The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. Am J Sports Med 2012;40:1742-1749. [PubMed] [Google Scholar]
​
8. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy 2012;28:998-1009. [PubMed] [Google Scholar]
​
9. Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg 2009;17:602-608. [PubMed] [Google Scholar]
​
10. Wasterlain AS, Braun HJ, Harris AH, Kim HJ, Dragoo JL. The systemic effects of platelet-rich plasma injection. Am J Sports Med 2013;41:186-193. [PubMed] [Google Scholar]
​